The deal range was $12.87-$13.09. RBC Capital acted as sole book running manager for the offering.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRMD:
- Closing Bell Movers: Nike gains 10% on more positive earnings call
- CorMedix announces $85M common stock offering
- CorMedix’s Promising Growth: Buy Rating Backed by Strong DefenCath Launch and Strategic Partnerships
- CorMedix Holds Annual Stockholders Meeting, Approves Key Proposals
- CorMedix Expands DefenCath Implementation with Major Client